Evidence of disease activity during pregnancy and post-partum in MS patients treated with high-efficacy therapies: a monocentric retrospective study

被引：0
|
作者：
Sahloul, Oussama [1 ]
Louapre, Celine [1 ]
Beigneux, Ysoline [1 ]
Lubetzki, Catherine [1 ]
Maillart, Elisabeth [1 ]
Roux, Thomas [1 ]
机构：
[1] Pitie Salpetriere Univ Hosp, Dept Neurol, AP HP, CRC SEP, Paris, France
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P062/219
引用
收藏
页码：182 / 182
页数：1
相关论文
共 40 条
  • [21] Impact of health beliefs, social support and self-efficacy on physical activity and dietary habits during the post-partum period after gestational diabetes mellitus: study protocol
    Kaiser, Barbara
    Razurel, Chantal
    Jeannot, Emilien
    BMC PREGNANCY AND CHILDBIRTH, 2013, 13
  • [22] Impact of health beliefs, social support and self-efficacy on physical activity and dietary habits during the post-partum period after gestational diabetes mellitus: study protocol
    Barbara Kaiser
    Chantal Razurel
    Emilien Jeannot
    BMC Pregnancy and Childbirth, 13
  • [23] Humoral immune response in convalescent COVID-19 people with multiple sclerosis treated with high-efficacy disease-modifying therapies: A multicenter, case-control study
    Habek, Mario
    Brecl, Gregor Jakob
    Kes, Vanja Basic
    Rogic, Dunja
    Barun, Barbara
    Gabelic, Tereza
    Emersic, Andreja
    Ledinek, Alenka Horvat
    Grbic, Nevena
    Lapic, Ivana
    Segulja, Dragana
    Duric, Koraljka
    Adamec, Ivan
    Skoric, Magdalena Krbot
    JOURNAL OF NEUROIMMUNOLOGY, 2021, 359
  • [24] Hepatitis B Virus (HBV) Variants in Untreated and Tenofovir Treated Chronic Hepatitis B (CHB) Patients During Pregnancy and Post-Partum Follow-up (vol 10, e0140070, 2015)
    Virine, Boris
    Osiowy, Carla
    Gao, Shan
    Wang, Tong
    Castillo, Eliana
    Martin, Steven R.
    Lee, Samuel S.
    Simmonds, Kimberley
    van Marle, Guido
    Coffin, Carla S.
    PLOS ONE, 2015, 10 (12):
  • [25] Efficacy and Safety Outcomes with Diroximel Fumarate in Patients with a History of Prior Sphingosine1-Phosphate Receptor Modulators or High-Efficacy Therapies as their Most Recent Therapy: Results from the Phase 3 EVOLVE-MS-1 Study
    Singer, B. A.
    Wray, S.
    England, S. M.
    Branco, F.
    Scaramozza, M.
    Levin, S.
    Chen, H.
    Yun, I.
    Bergh, F. Then
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 53 - 54
  • [26] Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study
    Giovannoni, Gavin
    Sorensen, Per Soelberg
    Cook, Stuart
    Rammohan, Kottil W.
    Rieckmann, Peter
    Comi, Giancarlo
    Dangond, Fernando
    Hicking, Christine
    Vermersch, Patrick
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (06) : 819 - 827
  • [27] Cortical glial activity is linked with serum GFAP levels and cortical atrophy in multiple sclerosis patients treated with high-efficacy DMTs: a [F-18] PBR06-PET study
    Singhal, Tarun
    Vaquerano, Steven
    Cicero, Steven
    Ficke, John Hunter
    Kukreja, Preksha
    Carter, Kelsey
    Pan, Hong
    Rissanen, Eero
    Chu, Renxin
    Tauhid, Shahamat
    Glanz, Bonnie
    Dubey, Shipra
    Bakshi, Rohit
    Chitnis, Tanuja
    Weiner, Howard
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 260 - 261
  • [28] The efficacy and safety of daclizumab high-yield process (DAC HYP) in patients previously treated with disease-modifying therapies: subgroup analyses from the DECIDE study
    Havrdova, E.
    Kappos, L.
    Selmaj, K.
    Arnold, D. L.
    Boyko, A.
    Kaufman, M.
    Wiendl, H.
    Rose, J.
    Greenberg, S.
    Sweetser, M.
    Wang, P.
    Barbato, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 152 - 152
  • [29] Assessment of unvaccinated and vaccinated patients with coronavirus disease 2019 (COVID-19) treated with monoclonal antibodies during the delta wave (July 1–August 20, 2021): a retrospective observational monocentric study
    Yi Guo
    Kelsie Cowman
    Mei Chang
    Hongkai Bao
    Austin Golia
    Terrence Mcsweeney
    Linda Bard
    Roxanne Simpson
    Erin Andrews
    Liise-anne Pirofski
    Priya Nori
    BMC Infectious Diseases, 22
  • [30] No evident disease activity in relapsing MS patients treated with interferon β-1a SC vs. interferon β-1a IM: subgroup analyses of the EVIDENCE study
    Coyle, P. K.
    Fang, J.
    Hassan, A.
    Cha, C.
    Dangond, F.
    Reder, A. T.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 114 - 114
1234